Haleon PLC EMTN programme publication of base prospectus (1763Z)
May 12 2023 - 4:30AM
UK Regulatory
TIDMHLN TIDMTTM TIDMTTM
RNS Number : 1763Z
Haleon PLC
12 May 2023
EMTN programme: publication of base prospectus
12 May 2023: Haleon plc (the "Company") (LSE/NYSE: HLN) today
announces that the base prospectus regarding Haleon UK Capital
plc's and Haleon Netherlands Capital B.V.'s GBP10,000,000,000 Euro
Medium Term Note ("EMTN") Programme, guaranteed by the Company, has
been published (the "Base Prospectus").
A copy of the Base Prospectus has been submitted to the National
Storage Mechanism and will shortly be available for inspection at
and can be downloaded from:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
and
https://www.haleon.com/investors/debt-investors
Ends
Investors Media
Sonya Ghobrial +44 7392 784784 Zoe Bird +44 7736 746167
Rakesh Patel +44 7552 484646 Nidaa Lone +44 7841 400607
Emma White +44 7823 523562
Email: investor-relations@haleon.com Email: corporate.media@haleon.com
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health,
with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans five major categories - Oral
Health, Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, parodontax and Centrum - are built on
trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Disclaimer
Please note that the information contained in the Base
Prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Base Prospectus is not addressed. Prior
to relying on the information contained in the Base Prospectus, you
must ascertain from the Base Prospectus whether or not you are part
of the intended addressees of the information contained in the Base
Prospectus.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PDIKFLFFXELBBBL
(END) Dow Jones Newswires
May 12, 2023 04:30 ET (08:30 GMT)
Haleon (LSE:HLN)
Historical Stock Chart
From Apr 2024 to May 2024
Haleon (LSE:HLN)
Historical Stock Chart
From May 2023 to May 2024